An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.
Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to WhatsApp for purchases.
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.
Several experts stated the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer laws, risking fines, legal action or imprisonment.
According to the social media company, the service has taken down problematic content and banned related hashtags and search suggestions. The company said it was dedicated to keeping the service secure and investing in strengthening compliance measures.
Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with images of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
After minutes of joining one group, a vendor posted contact information, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Inside these communities, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
A representative for the messaging service stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has already encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to possibly serious medical dangers”.
Milan is een ervaren opticien met een passie voor visuele technologie en klantgerichtheid.
